Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Biocon Limited — Rare Disease Pipeline | Kisho | Kisho
Biocon Limited
Other
3
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
acute graft versus host disease
itolizumab
Orphan Designation
-
dermatomyositis
humanized anti CD20 monoclonal antibody
Orphan Designation
-
← Back to Companies
